Work

Supplementary Figure S4 from Chromatin Regulators as a Guide for Cancer Treatment Choice

Year: 2023

Type: supplementary-materials

Abstract: A chromatin regulator gene panel can distinguish response in HER2+ patients treated with docetaxel

DOI: 10.1158/1535-7163.22508116

Authors: Zachary A. Gurard-Levin, Laurence O.W. Wilson, Vera Pancaldi, Sophie Postel-Vinay, Fabricio G. Sousa, Cecile Reyes, Elisabetta Marangoni, David Gentien, Alfonso Valencia, Yves Pommier, Paul Cottu, Geneviève Almouzni

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362610145

Cites:

Cited by:

Related to: 10